Free Trial

Avantor (AVTR) Competitors

$24.08
+0.48 (+2.03%)
(As of 05/31/2024 08:50 PM ET)

AVTR vs. A, MTD, WAT, ILMN, RVTY, BRKR, BIO, BIO.B, OLK, and TXG

Should you be buying Avantor stock or one of its competitors? The main competitors of Avantor include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Revvity (RVTY), Bruker (BRKR), Bio-Rad Laboratories (BIO), Bio-Rad Laboratories (BIO.B), Olink Holding AB (publ) (OLK), and 10x Genomics (TXG). These companies are all part of the "analytical instruments" industry.

Avantor vs.

Avantor (NYSE:AVTR) and Agilent Technologies (NYSE:A) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, profitability, valuation, risk, institutional ownership, community ranking and dividends.

Avantor has a beta of 1.36, meaning that its stock price is 36% more volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500.

In the previous week, Agilent Technologies had 35 more articles in the media than Avantor. MarketBeat recorded 46 mentions for Agilent Technologies and 11 mentions for Avantor. Avantor's average media sentiment score of 0.95 beat Agilent Technologies' score of 0.21 indicating that Avantor is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Avantor
4 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Agilent Technologies
10 Very Positive mention(s)
1 Positive mention(s)
11 Neutral mention(s)
8 Negative mention(s)
0 Very Negative mention(s)
Neutral

Avantor currently has a consensus target price of $26.71, indicating a potential upside of 10.94%. Agilent Technologies has a consensus target price of $137.19, indicating a potential upside of 5.20%. Given Avantor's stronger consensus rating and higher possible upside, equities analysts clearly believe Avantor is more favorable than Agilent Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avantor
0 Sell rating(s)
4 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.75
Agilent Technologies
1 Sell rating(s)
5 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.56

Agilent Technologies has lower revenue, but higher earnings than Avantor. Agilent Technologies is trading at a lower price-to-earnings ratio than Avantor, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avantor$6.97B2.35$321.10M$0.3961.74
Agilent Technologies$6.83B5.59$1.24B$4.2330.83

Agilent Technologies received 686 more outperform votes than Avantor when rated by MarketBeat users. Likewise, 71.70% of users gave Agilent Technologies an outperform vote while only 63.64% of users gave Avantor an outperform vote.

CompanyUnderperformOutperform
AvantorOutperform Votes
168
63.64%
Underperform Votes
96
36.36%
Agilent TechnologiesOutperform Votes
854
71.70%
Underperform Votes
337
28.30%

Agilent Technologies has a net margin of 18.84% compared to Avantor's net margin of 3.79%. Agilent Technologies' return on equity of 26.25% beat Avantor's return on equity.

Company Net Margins Return on Equity Return on Assets
Avantor3.79% 13.01% 5.22%
Agilent Technologies 18.84%26.25%14.45%

95.1% of Avantor shares are owned by institutional investors. 1.5% of Avantor shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Avantor and Agilent Technologies tied by winning 9 of the 18 factors compared between the two stocks.

Get Avantor News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVTR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVTR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVTR vs. The Competition

MetricAvantorAnalytical instruments IndustryMedical SectorNYSE Exchange
Market Cap$16.36B$5.11B$4.84B$17.67B
Dividend YieldN/A0.43%5.23%3.51%
P/E Ratio61.7425.13164.6725.68
Price / Sales2.354.882,401.9010.07
Price / Cash14.3535.9933.2819.13
Price / Book3.062.285.475.64
Net Income$321.10M-$10.98M$100.71M$973.36M
7 Day Performance-0.25%-1.83%116.26%2.09%
1 Month Performance-2.61%-6.02%118.51%4.61%
1 Year Performance20.28%-28.00%126.90%22.79%

Avantor Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
A
Agilent Technologies
4.3544 of 5 stars
$145.48
-1.8%
$141.06
-3.0%
+10.3%$43.43B$6.83B34.6418,100Earnings Report
Analyst Forecast
Short Interest ↓
Analyst Revision
MTD
Mettler-Toledo International
3.5401 of 5 stars
$1,440.54
-1.0%
$1,257.14
-12.7%
+5.4%$31.07B$3.79B40.4017,300Analyst Revision
Positive News
WAT
Waters
3.836 of 5 stars
$327.65
-1.3%
$305.78
-6.7%
+19.4%$19.68B$2.96B32.157,900Analyst Revision
ILMN
Illumina
4.7008 of 5 stars
$101.76
-3.1%
$164.65
+61.8%
-49.7%$16.73B$4.50B-12.499,300Short Interest ↑
RVTY
Revvity
2.1951 of 5 stars
$109.75
-1.9%
$118.17
+7.7%
-5.2%$13.80B$2.75B90.7011,500Positive News
BRKR
Bruker
4.8897 of 5 stars
$72.55
-4.4%
$85.00
+17.2%
-8.2%$11.03B$2.96B26.389,707Gap Down
BIO
Bio-Rad Laboratories
4.7973 of 5 stars
$284.94
-0.4%
$461.00
+61.8%
-23.0%$8.16B$2.67B-27.508,030Short Interest ↓
Analyst Revision
BIO.B
Bio-Rad Laboratories
0 of 5 stars
$279.91
flat
N/A-24.6%$7.98B$2.67B-27.027,900Positive News
Gap Down
OLK
Olink Holding AB (publ)
0.1757 of 5 stars
$24.03
+0.0%
$26.00
+8.2%
+20.3%$2.99B$169.60M-89.00707Positive News
TXG
10x Genomics
4.7229 of 5 stars
$22.11
-2.6%
$48.50
+119.4%
-58.9%$2.71B$618.73M-9.911,259Gap Down

Related Companies and Tools

This page (NYSE:AVTR) was last updated on 6/3/2024 by MarketBeat.com Staff

From Our Partners